Article
Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism.
Circulation - 3 Jan 2006
McNulty Helene, Dowey Le Roy C, Strain J J, Dunne Adrian, Ward Mary, Molloy Anne M, McAnena Liadhan B, Hughes Joan P, Hannon-Fletcher Mary, Scott John M
Abstract excerpt
BACKGROUND: Meta-analyses predict that a 25% lowering of plasma homocysteine would reduce the risk of coronary heart disease by 11% to 16% and stroke by 19% to 24%. Individuals homozygous for the methylenetetrahydrofolate reductase (MTHFR) 677C-->T polymorphism have reduced MTHFR enzyme activity resulting from the inappropriate loss of the riboflavin cofactor, but it is unknown whether their typically high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
